Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8485516 | Vaccine | 2018 | 5 Pages |
Abstract
Countries with local influenza vaccine manufacturing capacity should include in their seasonal influenza vaccine procurement process an analysis of the pros- and cons- of TIV versus QIV, to ensure both feasibility and sustainability of local manufacturing.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Jan Hendriks, Raymond C.W. Hutubessy, Gary Grohmann, Guido Torelli, Martin Friede, Marie-Paule Kieny,